Press
LATEST NEWS
Gedeon Richter and Myovant Sciences Receive Positive CHMP Opinion for RYEQO® (Relugolix Combination Tablet) for the Treatment of Uterine Fibroids
in News, Press Releases onRead more21 May 2021 Budapest, Hungary – 21 May 2021 – Gedeon Richter Plc. (“Richter”) announces that the Committee for…
0Gedeon Richter and Myovant Sciences Enter into Exclusive License Agreement to Commercialize Relugolix Combination Tablet for Uterine Fibroids and Endometriosis in Certain Territories Outside the U.S.
in News, Press Releases onRead more31 March 2020 Budapest, Hungary and Basel, Switzerland – Myovant Sciences (NYSE:MYOV), a healthcare company focused on developing innovative…
LATEST PUBLICATIONS
Careers
A career at Preglem® is more than just a job. It gives you the opportunity to solve challenging global problems in a way that can change the world.
Contact us
In line with our corporate culture, we treat all information received with full confidentiality.